LOI

Btab Ecommerce Group Signs LOI to Merge with Integrated Wellness Acquisition Corp

Retrieved on: 
Thursday, February 15, 2024

SYDNEY, Australia, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Btab Ecommerce Group, Inc., an e-commerce company (OTC: BBTT) (“BTAB” or the “Company”), and Integrated Wellness Acquisition Corp, a special purpose acquisition company (NYSE: WEL) (“WEL” or “Integrated Wellness”), today announced that they have entered into a Letter of Intent (the "LOI") providing for a proposed business combination (the "Transaction") that will result in BTAB acquiring control of WEL.

Key Points: 
  • SYDNEY, Australia, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Btab Ecommerce Group, Inc., an e-commerce company (OTC: BBTT) (“BTAB” or the “Company”), and Integrated Wellness Acquisition Corp, a special purpose acquisition company (NYSE: WEL) (“WEL” or “Integrated Wellness”), today announced that they have entered into a Letter of Intent (the "LOI") providing for a proposed business combination (the "Transaction") that will result in BTAB acquiring control of WEL.
  • The Transaction values BTAB at an initial enterprise value of U.S. $250 million.
  • Under the terms of the LOI, subject to negotiation and signing a definitive agreement, WEL will issue both common and preferred shares in exchange for the shares in BTAB.
  • Subject to the signing of definitive agreements, the Transaction is anticipated to be completed in the second half of this year.

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

Retrieved on: 
Thursday, February 15, 2024

LOS ANGELES and AMSTERDAM, Feb. 15, 2024 (GLOBE NEWSWIRE) -- GEDiCube (moving forward RenovaroCube), a London and Netherlands-based advanced AI company and a wholly owned subsidiary of Renovaro Inc. (NASDAQ: RENB), announces it has executed a binding Letter of Intent (LOI) to acquire 75% of Cyclomics, a Dutch Company. Under the terms of the LOI, the parties have agreed to work in good faith on the drafting of a definitive agreement.

Key Points: 
  • Expected breakthroughs by combining technologies in (early) cancer detection and recurrence of cancer with a single vial of blood.
  • Cyclomics’ 4th generation liquid biopsy genomics platform is the first truly “Omni-Omic” blood test ready for AI application.
  • Under the terms of the LOI, the parties have agreed to work in good faith on the drafting of a definitive agreement.
  • The focus is on early cancer- and early recurrence detection, prediction of response to therapy, and personalized treatment, all via liquid biopsy tests.

Statement of Renovaro Inc

Retrieved on: 
Wednesday, February 14, 2024

LOS ANGELES, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The following is a statement by Renovaro (Nasdaq: RENB) in response to Hindenburg's recent opinion piece:

Key Points: 
  • LOS ANGELES, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The following is a statement by Renovaro (Nasdaq: RENB) in response to Hindenburg's recent opinion piece:
    We felt compelled to comment on the shorter Hindenburg’s opinion piece.
  • The one thing Hindenburg got right is that the Board of the Company has remained steadfast in their confidence and support in the lifesaving potential of Renovaro.
  • In fact, four exceptional leaders in the field of technology and business have recently joined the Board.
  • Hindenburg Research makes no representation, express or implied, as to the accuracy, timeliness, or completeness of any such information….

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

Retrieved on: 
Tuesday, February 13, 2024

LOS ANGELES, Feb. 13, 2024 (GLOBE NEWSWIRE) -- GEDi Cube Intl Ltd., a London and Netherlands-based advanced AI company and a wholly owned subsidiary of Renovaro Inc. (NASDAQ: RENB), announces it has executed a binding Letter of Intent (LOI) to acquire 75% of Cyclomics, a Dutch Company. Under the terms of the LOI, the parties have agreed to work in good faith on the drafting of a definitive agreement.

Key Points: 
  • Expected breakthroughs by combining technologies in (early) cancer detection and recurrence of cancer with a single vial of blood.
  • The combined Companies aim to Disrupt Cancer Diagnosis and treatment through early disease and recurrence detection, prediction of response to treatment, and personalized therapy.
  • Under the terms of the LOI, the parties have agreed to work in good faith on the drafting of a definitive agreement.
  • I consider that to be a significant step towards bringing early detection of cancer to its inflection point.”

LITHIUM LION ENTERS INTO BINDING LETTER OF INTENT FOR THE BOULDER CREEK PROPERTY

Retrieved on: 
Monday, February 12, 2024

Vancouver, British Columbia, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Lithium Lion Metals Inc. (“Lithium Lion” or the “Company”) (CSE: LLM) (OTC: GLIOF) (FWB: 2BC), is pleased to announce the Company has entered into a binding Letter of Intent (the “LOI”), dated February 12, 2024, with Tubutulik Mining Company LLC (“TMC”) for the Boulder Creek Property (the “Property”).

Key Points: 
  • Vancouver, British Columbia, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Lithium Lion Metals Inc. (“Lithium Lion” or the “Company”) (CSE: LLM) (OTC: GLIOF) (FWB: 2BC), is pleased to announce the Company has entered into a binding Letter of Intent (the “LOI”), dated February 12, 2024, with Tubutulik Mining Company LLC (“TMC”) for the Boulder Creek Property (the “Property”).
  • The Company will grant TMC a 2.0% net smelter royalty on the Property and any area of interest, as further provided for in the Definitive Agreement.
  • A finders fee is payable to Robert Weicker in an amount equal to 7.00% per Option Payment will also be applicable.
  • Lithium Lion is currently conducting technical due diligence on the Property, and upon satisfactory results, expects to enter into the Definitive Agreement within 60 days.

Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device

Retrieved on: 
Thursday, February 8, 2024

RA'ANANA, Israel, Feb. 8, 2024 /PRNewswire/ -- Inspira Technologies OXY BHN Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, has announced the signing of a non-binding Letter of Intent (LOI) with Shamir Medical Center (Assaf Harofeh), a renowned healthcare institution in central Israel. The Company plans to extend collaborations with further leading Israeli medical centers as part of a wider clinical deployment strategy.

Key Points: 
  • The Company plans to extend collaborations with further leading Israeli medical centers as part of a wider clinical deployment strategy.
  • The LOI solidifies the mutual commitment of both parties to assess the integration and performance of the INSPIRA™ ART100 device ("Device) within Shamir Medical Center's clinical environment.
  • This includes evaluating the device's fit with the hospital's clinical needs, efficiency in workflow, and overall impact on healthcare delivery.
  • The evaluation will be led by Dr. Eduard Ilgiyaev, Director of the Intensive Care Unit at Shamir Medical Center and a leading pioneer of critical care medicine in Israel.

American Blockchain Corporation to Raise $15 million

Retrieved on: 
Tuesday, February 6, 2024

Henderson, NV, Feb. 06, 2024 (GLOBE NEWSWIRE) -- American Blockchain Corporation (“ABC”), trading as Good Vibrations Shoes, Inc. (OTCMKT: GVSI), announced today that it has entered into a non-binding Letter of Intent (“LOI”) with a privately owned Blockchain and Cryptocurrency enterprise, currently operating as an LLC.

Key Points: 
  • Henderson, NV, Feb. 06, 2024 (GLOBE NEWSWIRE) -- American Blockchain Corporation (“ABC”), trading as Good Vibrations Shoes, Inc. (OTCMKT: GVSI), announced today that it has entered into a non-binding Letter of Intent (“LOI”) with a privately owned Blockchain and Cryptocurrency enterprise, currently operating as an LLC.
  • Under the terms of the LOI, GVSI will raise $15 million on a “best-efforts” basis for investment in the LLC, in exchange for 35% equity membership in the LLC.
  • Potential GVSI investors have already been identified by the LLC, which has previously and privately raised $9 million under a $30 million valuation.
  • The LOI also provides Worldwide NFT, Inc. (OTCMKT: WNFT) the opportunity to provide the final $2 million of the $15 million investment into GVSI, dependent on WNFT’s ability to raise these funds.

Premier Diversified Holdings Inc. Announces Cease Trade Order and Provides Update on the Proposed Acquisition of AJA Health and Wellness Ltd., Assured Diagnosis Inc., and AJA Therapeutics Inc.

Retrieved on: 
Monday, February 5, 2024

VANCOUVER, British Columbia, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Premier Diversified Holdings Inc. ("PDH" or the "Company") (TSXV:PDH) announces that further to the press release dated January 18, 2024, whereby the Company announced the filing of an application seeking a management cease trade order (“MCTO”) from the British Columbia Securities Commission (“BCSC”) due to its inability to file its annual financial statements for the year ending September 30, 2023 including the related management’s discussion and analysis and certifications from the CEO and CFO (the “Annual Filings”), the BCSC will issue a cease trade order against PDH (the “CTO”).

Key Points: 
  • The Corporation continues to pursue the acquisitions of AJA Health and Wellness Ltd. ("AJA Health"), AJA Therapeutics Inc. ("ATI"), and Assured Diagnosis Inc. ("ADI", and together with PDH, AJA Health, and ATI, the "Parties").
  • The Acquisition, subject to certain conditions and applicable shareholder and regulatory approvals, will result in a reverse takeover of PDH.
  • There can be no assurance that the Acquisition will be completed as proposed or at all.
  • AJA Health and ADI are diligently working on having audits completed on their financial statements.

Global Warming Solutions Announces Plan to Revolutionize Hydrogen Production and Distribution in Kansas

Retrieved on: 
Tuesday, January 30, 2024

Temecula, CA, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Global Warming Solutions Inc. (OTCQB: $GWSO), a world leader in renewable hydrogen solutions, announced today its vision to revolutionize hydrogen production and delivery in the state of Kansas through a new partnership with Coal Creek Energy.

Key Points: 
  • Temecula, CA, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Global Warming Solutions Inc. (OTCQB: $GWSO), a world leader in renewable hydrogen solutions, announced today its vision to revolutionize hydrogen production and delivery in the state of Kansas through a new partnership with Coal Creek Energy.
  • The company plans to immediately lease an additional 10,000 acres and begin exploratory drilling to evaluate the potential for scalable, economical hydrogen production.
  • The announcement comes as automakers like GM and Honda begin ramping up fuel cell production to meet growing demand for hydrogen-powered vehicles.
  • This agreement sets the stage for GWSO to transform hydrogen into a widely available mainstream fuel source," said Michael Pollastro, CEO of Global Warming Solutions.

Port Houston Highlights 2023 Achievements

Retrieved on: 
Thursday, February 1, 2024

Last week, the Port Commission of the Port of Houston Authority met for its first regular meeting of the year.

Key Points: 
  • Last week, the Port Commission of the Port of Houston Authority met for its first regular meeting of the year.
  • In his report to the Port Commission, Executive Director Roger Guenther highlighted the many achievements of 2023.
  • In 2023, Minority and Woman-owned Business Enterprises (MWBEs) participated in 16% or $65.95 million in Port Houston awards, representing 8% growth over 2022.
  • Finally, Guenther announced that Port Houston was recognized by Gallagher as a “2023 Best-in-Class Employer,” and for the forty-ninth year in a row, the Government Finance Officers Association had awarded Port Houston its Certificate of Achievement for Excellence in Financial Reporting, for its 2022 Annual Comprehensive Financial Report.